Among the 174 patients with documented ABP, there were 54 men and 120 women. In 92 patients (53%) the bile cultures were sterile, whereas 82 patients (47%) had a positive bile culture. The time ...

Acute cholangitis is a severe, bacterial infection of the biliary tract precipitated by an obstruction that often results in systemic inflammation and, in some cases, life‐threatening sepsis. This ...

Biliary tract infection (BTI) is a disease with high morbidity and mortality, often associated with structural abnormalities such as common bile duct stones and malignant tumors. Although Pseudomonas ...

Please provide your email address to receive an email when new articles are posted on . Compared with other maternal infections, intestinal infection and genitourinary tract infection increased the ...

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA on Wednesday granted accelerated approval to zanidatamab ...

An expert explains what biliary tract cancers are and the current landscape of treatment as well as future advancements. In the treatment of newly diagnosed biliary tract cancer, the current standard ...

Results showed the ORR was 17.1% in the tovecimig plus paclitaxel arm compared with 5.3% in the paclitaxel alone arm. Topline data were announced from a phase 2/3 trial evaluating tovecimig in ...

Authors wrote that their analysis was the first to combine incidence and mortality of overall BTC, and its anatomic subtypes, into a single study Biliary tract cancer (BTC), a category that includes ...

BRAF-Mutated Advanced Colorectal Cancer: A Rapidly Changing Therapeutic Landscape Precision medicine has become a dominant theme in the treatment of biliary tract cancers (BTCs). Although prognosis ...

Biliary tract cancers, including intrahepatic, perihilar, and extrahepatic cholangiocarcinoma and gallbladder cancer, are among the most aggressive gastrointestinal malignancies. Treatment options ...

Credit: Jazz Pharmaceuticals Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor. Findings showed the ORR was 52% (95% CI, 39-65), of which ...